CONTAK RENEWAL
A Cardiac Resynchronization Therapy Defibrillator (CRT-D) Related Image
(Not Necessarily related to the device)Description:
CONTAK RENEWAL by Boston Scientific Corp.
The CONTAK RENEWAL is a highly advanced, innovative cardiac resynchronization therapy defibrillator (CRT-D) engineered by globally recognized healthcare technology leaders, Boston Scientific Corp. This ground-breaking device leverages state-of-the-art technology to not only monitor and regulate heart rhythm but also to provide life-saving defibrillation therapy.
The primary use of the CONTAK RENEWAL is to manage and treat ventricular and atrial cardiac arrhythmias. This addresses both fast and slow heart beat irregularities, effectively reducing the risk of sudden cardiac arrest and heart failure.
The device goes beyond just treatment and introduces a new era of proactive patient management. It comes armed with heart failure sensor technology, which collects data continuously to predict potential heart failure events in advance. This enables a more proactive approach to patient care, allowing medical professionals to act expediently in response to the person's health needs.
CONTAK RENEWAL is designed for patient comfort and practicability with a minimalistic and lightweight design that eases patient mobility and lifestyle adaptability. The device also offers a longer battery life, necessitating fewer device replacement procedures, and subsequently a better quality of life for the patient.
On the whole, CONTAK RENEWAL offers a harmonious blend of revolutionary design and leading-edge technology to improve the lives of patients with heart diseases. Its user-friendly design, coupled with its primary clinical benefits, make it a significant contributor to modern cardiac care.
Primary Use:
Overview of CONTAK RENEWAL
The device in question, CONTAK RENEWAL, doesn't fall under the 'Orthopedic Implants' category. Instead, it's a sophisticated piece of cardiology equipment, more specifically a Cardiac Resynchronization Therapy Defibrillator (CRT-D).Primary Use
The main medical use of CONTAK RENEWAL is to monitor and, when necessary, correct arrhythmias detected in the patient's heart rhythm. These irregularities or arrhythmias can lead to significant complications, including heart failure and even cardiac arrest. The CONTAK RENEWAL device is implantable, and it helps the heart's chambers beat together in a more synchronized pattern (resynchronization), improving the efficiency of a weak heart. It also has a built-in defibrillator toHow It Works:
Overview of the Contak Renewal
The Contak Renewal is a critical medical device used within the field of cardiac electrophysiology. Contrary to the category provided, it's pertinent to note this device falls under the 'Cardiac Rhythm Management Devices' class, rather than 'Orthopedic Implants'. The Contak Renewal functions as a biventricular Automatic Implantable Cardioverter Defibrillator (AICD), uniquely designed to diagnose and treat life-threatening episodes of ventricular arrhythmias.
Functionality of the Contak Renewal
The efficacy of the Contak Renewal is premised on two key components: defibrillation and cardiac resynchronization therapy (CRT). The AICD component is essentially the device's crucial lifeline, responsible for delivering electrical shock to the heart when it detects malignant arrhythmias like ventricular fibrillation or ventricular tachycardia. This prompt action can significantly reduce the risk of sudden cardiac death.
Now, the CRT component of the Contak Renewal is primarily responsible for optimizing the heart's pumping efficiency in patients suffering from congestive heart failure. It achieves this by rectifying the asynchronous myocardial contractions in the ventricles through timed electrical stimuli.
Placement and Monitoring
Deployment of the Contak Renewal involves a surgical procedure where the device is essentially implanted in the upper chest. Leads are then affixed to the ventricles and sometimes the atrium. The device continuously monitors electrical activity, treats arrhythmias, and improves overall heart function.
Moreover, the Contak Renewal system is capable of real-time diagnostic data collection, which can be retrieved and analyzed during a patient’s follow-up clinic visits. These data are crucial in adjusting therapies and tracking disease progression. In conclusion, the Contak Renewal plays a critical role in mitigating the risk of sudden cardiac death, better managing heart failure, and improving patients' quality of life. The potential for its advancement in future incarnations promises even greater efficiency in saving lives and improving health outcomes.
Manufacturer:
Boston Scientific Corp.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.